Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16599342 [patent_doc_number] => 20210025873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => METHODS OF IDENTIFYING AND MONITORING MITOCHONDRIAL DYSFUNCTION USING MONOCYTE SCREENING [patent_app_type] => utility [patent_app_number] => 16/845687 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845687 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/845687
Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening Apr 9, 2020 Issued
Array ( [id] => 16598386 [patent_doc_number] => 20210024917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => Methods for Enhancing Bacterial Cell Display of Proteins and Peptides [patent_app_type] => utility [patent_app_number] => 16/843329 [patent_app_country] => US [patent_app_date] => 2020-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843329 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/843329
Methods for Enhancing Bacterial Cell Display of Proteins and Peptides Apr 7, 2020 Abandoned
Array ( [id] => 17134828 [patent_doc_number] => 11136374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Polypeptides and medical uses thereof [patent_app_type] => utility [patent_app_number] => 16/839155 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 20729 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839155 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/839155
Polypeptides and medical uses thereof Apr 2, 2020 Issued
Array ( [id] => 17362671 [patent_doc_number] => 11229679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-25 [patent_title] => Compositions for treating heart disease by inhibiting the action of mAKAPb [patent_app_type] => utility [patent_app_number] => 16/837633 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 47 [patent_no_of_words] => 23707 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837633 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/837633
Compositions for treating heart disease by inhibiting the action of mAKAPb Mar 31, 2020 Issued
Array ( [id] => 17625873 [patent_doc_number] => 20220160888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => CP2C-TARGETING PEPTIDE-BASED ANTICANCER AGENT [patent_app_type] => utility [patent_app_number] => 17/600760 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/600760
CP2C-targeting peptide-based anticancer agent Mar 31, 2020 Issued
Array ( [id] => 17680045 [patent_doc_number] => 11364276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Antiviral peptides for treatment of the middle east respiratory syndrome [patent_app_type] => utility [patent_app_number] => 16/831187 [patent_app_country] => US [patent_app_date] => 2020-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 15031 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831187 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/831187
Antiviral peptides for treatment of the middle east respiratory syndrome Mar 25, 2020 Issued
Array ( [id] => 17609885 [patent_doc_number] => 20220152164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => GPCR COMBINATION THERAPIES [patent_app_type] => utility [patent_app_number] => 17/440901 [patent_app_country] => US [patent_app_date] => 2020-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440901
GPCR COMBINATION THERAPIES Mar 18, 2020 Abandoned
Array ( [id] => 20264135 [patent_doc_number] => 12435111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Mutant VSV ectodomain polypeptide and uses thereof [patent_app_type] => utility [patent_app_number] => 17/439166 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16084 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439166 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/439166
Mutant VSV ectodomain polypeptide and uses thereof Mar 15, 2020 Issued
Array ( [id] => 17657062 [patent_doc_number] => 20220177527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS OF DETECTING AND TREATING HEREDITARY SPASTIC PARAPLEGIA [patent_app_type] => utility [patent_app_number] => 17/439338 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439338 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/439338
METHODS OF DETECTING AND TREATING HEREDITARY SPASTIC PARAPLEGIA Mar 12, 2020 Abandoned
Array ( [id] => 16837994 [patent_doc_number] => 20210146006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER [patent_app_type] => utility [patent_app_number] => 16/814613 [patent_app_country] => US [patent_app_date] => 2020-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814613 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/814613
COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER Mar 9, 2020 Abandoned
Array ( [id] => 17306340 [patent_doc_number] => 11207423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs [patent_app_type] => utility [patent_app_number] => 16/814567 [patent_app_country] => US [patent_app_date] => 2020-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20192 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814567 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/814567
Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs Mar 9, 2020 Issued
Array ( [id] => 16296294 [patent_doc_number] => 20200282017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => COMPOSITIONS AND METHOD FOR REDUCING VIRULENCE OF MICROORGANISMS [patent_app_type] => utility [patent_app_number] => 16/807792 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807792 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/807792
Compositions and method for reducing virulence of microorganisms Mar 2, 2020 Issued
Array ( [id] => 17769375 [patent_doc_number] => 11401303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-02 [patent_title] => Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof [patent_app_type] => utility [patent_app_number] => 17/310121 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 8774 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310121
Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof Mar 2, 2020 Issued
Array ( [id] => 17627263 [patent_doc_number] => 20220162278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY [patent_app_type] => utility [patent_app_number] => 17/433009 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21688 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433009 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/433009
CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY Feb 26, 2020 Pending
Array ( [id] => 16091155 [patent_doc_number] => 20200199564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/787456 [patent_app_country] => US [patent_app_date] => 2020-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787456 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/787456
FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION Feb 10, 2020 Abandoned
Array ( [id] => 16598117 [patent_doc_number] => 20210024648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => MODIFIED PSEUDOMONAS EXOTOXIN A [patent_app_type] => utility [patent_app_number] => 16/785911 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785911 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/785911
MODIFIED PSEUDOMONAS EXOTOXIN A Feb 9, 2020 Abandoned
Array ( [id] => 16053201 [patent_doc_number] => 20200188455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => TUBE FEED FORMULATIONS AND METHODS FOR USING SAME [patent_app_type] => utility [patent_app_number] => 16/782336 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18185 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782336 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782336
TUBE FEED FORMULATIONS AND METHODS FOR USING SAME Feb 4, 2020 Abandoned
Array ( [id] => 17505150 [patent_doc_number] => 20220098252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => INHIBITOR OF DUX4 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/425359 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425359 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/425359
INHIBITOR OF DUX4 AND USES THEREOF Jan 26, 2020 Abandoned
Array ( [id] => 17441874 [patent_doc_number] => 20220062379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION [patent_app_type] => utility [patent_app_number] => 17/423244 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -83 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/423244
METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION Jan 16, 2020 Abandoned
Array ( [id] => 19975944 [patent_doc_number] => 12343400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-01 [patent_title] => Brain tumor-targeting peptide and application thereof [patent_app_type] => utility [patent_app_number] => 17/295566 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 0 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295566 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295566
Brain tumor-targeting peptide and application thereof Jan 16, 2020 Issued
Menu